New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours: San Francisco Saturday, July 26, 2025, 12 ...

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

The immune cell repertoire is composed of many different cell types that are orchestrated in response to infection and other ...

The global research initiative co-founded in 2020 by Cancer Research UK (London, UK) and the National Cancer Institute (MD, ...

Cellular senescence—an irreversible cell-cycle arrest coupled with the production of pro-inflammatory secretions known as ...

A breakthrough for the customized treatment of cancer and other diseases is so promising that University of Washington ...

GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonstrates ...

A groundbreaking UCSF study challenges the long-held belief that blood is solely produced in bone marrow. Researchers ...

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of ...

Like AI, cells change and learn from experience, while unlike computer chips they arrive naturally preprogrammed ...

Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...